<bill session="114" type="h" number="2005" updated="2018-11-21T21:23:04Z">
  <state datetime="2015-04-23">REFERRED</state>
  <status>
    <introduced datetime="2015-04-23"/>
  </status>
  <introduced datetime="2015-04-23"/>
  <titles>
    <title type="short" as="introduced">Medicare Drug Savings Act of 2015</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to require drug manufacturers to provide drug rebates for drugs dispensed to low-income individuals under the Medicare prescription drug benefit program.</title>
    <title type="display">Medicare Drug Savings Act of 2015</title>
  </titles>
  <sponsor bioguide_id="C001066"/>
  <cosponsors>
    <cosponsor bioguide_id="B001292" joined="2016-02-03"/>
    <cosponsor bioguide_id="B000574" joined="2016-02-04"/>
    <cosponsor bioguide_id="B000911" joined="2015-06-03"/>
    <cosponsor bioguide_id="C001090" joined="2015-06-03"/>
    <cosponsor bioguide_id="D000623" joined="2015-07-23"/>
    <cosponsor bioguide_id="E000290" joined="2015-09-16"/>
    <cosponsor bioguide_id="G000551" joined="2015-06-08"/>
    <cosponsor bioguide_id="H001034" joined="2016-01-28"/>
    <cosponsor bioguide_id="L000551" joined="2015-06-04"/>
    <cosponsor bioguide_id="L000263" joined="2015-04-23"/>
    <cosponsor bioguide_id="L000579" joined="2015-06-08"/>
    <cosponsor bioguide_id="P000607" joined="2015-06-04"/>
    <cosponsor bioguide_id="S001145" joined="2015-06-08"/>
    <cosponsor bioguide_id="T000472" joined="2015-06-08"/>
    <cosponsor bioguide_id="T000468" joined="2015-07-08"/>
  </cosponsors>
  <actions>
    <action datetime="2015-04-23">
      <text>Introduced in House</text>
    </action>
    <action datetime="2015-04-23" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2015-04-23">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2015-04-24">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2015-05-13">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="Health" code="HSWM02" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="114" relation="identical" number="1083"/>
    <bill type="h" session="114" relation="unknown" number="3513"/>
    <bill type="s" session="114" relation="unknown" number="2023"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Health care costs and insurance"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
    <term name="Retail and wholesale trades"/>
  </subjects>
  <amendments/>
  <summary date="2015-04-23T04:00:00Z" status="Introduced in House">Medicare Drug Savings Act of 2015

 Amends part D (Voluntary Prescription Drug Benefit Program) of title XVIII (Medicare) of the Social Security Act (SSAct) to require drug manufacturers to pay the Secretary of Health and Human Services drug rebates for rebate eligible (low-income) individuals. Excludes from Medicare coverage as a part D drug any drug or biological manufactured by a manufacturer that has not entered into and have in effect a rebate agreement with the Secretary.

Requires a rebate agreement to require a drug or biological manufacturer to provide to the Secretary a rebate, determined according to a specified formula, for each rebate period ending after December 31, 2015, for any covered Medicare part D drug dispensed after that date to any rebate eligible individual for which payment was made by a prescription drug plan sponsor or MedicareAdvantage organization for such period.

Specifies a formula for determination of Medicaid rebate amounts for such drugs or biologicals.

Amends SSAct title XIX (Medicaid) to exclude any amounts paid under a rebate agreement from the determination of best price and average manufacturer price under the Medicaid program.</summary>
  <committee-reports/>
</bill>
